Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Atai Life Sciences N.V. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ATAI
Nasdaq
2830
atai.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Atai Life Sciences N.V.
Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target
- Jul 11th, 2025 5:13 pm
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
- Jul 11th, 2025 7:40 am
Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy Rating
- Jul 9th, 2025 8:36 am
Atai Life Sciences, Beckley Psytech Announce Positive Topline Results for BPL-003
- Jul 9th, 2025 5:19 am
The MAHA Movement Loves Psychedelics. Should Wall Street?
- Jul 6th, 2025 3:30 am
Retail investors are Atai Life Sciences N.V.'s (NASDAQ:ATAI) biggest owners and were rewarded after market cap rose by US$121m last week
- Jul 3rd, 2025 5:38 am
A Promising Depression Drug Works. Psychedelics Are Back.
- Jul 1st, 2025 1:06 pm
atai and Beckley Psytech’s psychedelic wins in Phase IIb depression trial
- Jul 1st, 2025 10:04 am
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
- Jul 1st, 2025 7:27 am
Atai and Beckley, set to merge, reveal study success for psychedelic drug
- Jul 1st, 2025 5:15 am
atai Life Sciences Announces $50 Million Private Placement Financing
- Jul 1st, 2025 4:05 am
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
- Jul 1st, 2025 4:00 am
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
- Jun 25th, 2025 7:40 am
Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target
- Jun 24th, 2025 1:51 pm
Trump Trade: President said to weigh possible U.S. strike against Iran
- Jun 19th, 2025 8:10 am
Psychedelic advocates hopeful Trump administration will support space, STAT says
- Jun 19th, 2025 7:26 am
This Illegal Psychedelic Is Hailed as a ‘Revolutionary Breakthrough’
- Jun 18th, 2025 10:01 pm
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
- Jun 2nd, 2025 4:00 am
atai Life Sciences to Participate in Upcoming Investor Conferences
- May 29th, 2025 6:30 am
Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies
- May 21st, 2025 10:10 am
Scroll